Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry
You may also be interested in...
Australia Ranked As Second Most Expensive Country For Clinical Trials; Medicines Australia Calls For Reform
A strong currency and cumbersome rules have contributed to Australia becoming the second-most expensive country for clinical trials, and neighboring countries are taking advantage.
Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
PERTH, Australia - An earlier proposal put forth to legislators by generics maker Hospira to ease restrictions on producing generics for export has been shot down
Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
PERTH, Australia - An earlier proposal put forth to legislators by generics maker Hospira to ease restrictions on producing generics for export has been shot down